Social media and pediatric mental health with Peter S. Jensen, MD ...

Youth nicotine pouch use and dual use with e-cigarettes increased from 2023 to 2024, highlighting the need for stronger prevention and regulation efforts. From 2023 to 2024, past-30-day nicotine pouch ...

Somapacitan was non-inferior and had a similar safety profile and clinical outcomes compared to once-daily somatropin in improving yearly growth rates. Novo Nordisk's once-weekly somapacitan (Sogroya) ...

Maternal avocado consumption during pregnancy was linked to significantly lower odds of infant food allergy at 12 months. Maternal consumption of avocado during pregnancy was associated with ...

The federal agency provided BioCryst Pharmaceuticals a target action date of September 12, 2025 for potential approval of berotralstat (ORLADEYO). On May 14, 2025, the FDA accepted a new drug ...

Safety, phosphate level gains, and immunogenicity data offer encouraging signals in the pivotal trial. Inozyme Pharma has announced interim results from its phase 3 ENERGY 3 trial evaluating INZ-701 ...

The US Preventive Services Task Force (USPSTF) has strongly reaffirmed a 2018 recommendation for early and universal screening for syphilis infection during pregnancy for adolescents and adults, ...

On May 12, 2025, the FDA cleared an investigational new drug application for Ensoma's lead program EN-374 in X-linked chronic granulomatous disease (X-CGD), according to a press release from genomic ...

According to the study investigators, led by Ingmar Fortmann, MD, animal models have previously suggested a link between early antibiotic exposure and airway disease. Similar associations have been ...

This FDA decision will help to improve clarity and diagnostic accuracy of echocardiograms in pediatric patients, according to GE HealthCare. On May 13, 2025, the FDA approved a pediatric indication ...

According to the agency, it is seeking public input to "determine whether existing nutrient requirements should be revised based on latest scientific data." The FDA and the US Department of Health and ...

Respiratory syncytial virus (RSV) illness is an extremely common cause of hospitalization in children in the United States and globally. An estimated 90% of children will be infected by 2 years of age ...